Quick Answer Box
What peptides are actually for sale in Canada in 2026? The Canadian peptide market has grown a lot in compound availability since 2024. Currently for sale across Canadian research peptide retailers: 40+ distinct research compounds spanning regenerative peptides (BPC-157, TB-500, GHK-Cu, KPV), GLP-1 class metabolic peptides (semaglutide, tirzepatide, retatrutide, cagrilintide), GH-secretagogues (CJC-1295, Ipamorelin, Sermorelin, MK-677, GHRP-2, GHRP-6), mitochondrial peptides (MOTS-c, SS-31), longevity peptides (epitalon, thymosin alpha-1), and specialty research compounds (PT-141, AOD9604, IGF-1 LR3, follistatin, 5-amino-1MQ, melanotan-2, KPV).
The leading Canadian source carrying the broadest documented catalog is Nox Peptides, the only Canadian retail-facing supplier publishing both purity AND endotoxin lab reports per batch across the full compound range.
What’s new for sale in Canada in 2026 vs 2024:
- Retatrutide: broader availability after Phase 3 trial validation
- Cagrilintide: more available as CagriSema clinical development moves forward
- Generic semaglutide (prescription pathway only): Dr. Reddy’s and Apotex got Health Canada approval in April–May 2026
- Combination blends (KLOW, GLOW, Wolverine Stack): wider catalog availability
- Larger vial formats: 45mg MOTS-c, 50mg BPC-157, 30mg+ retatrutide are now widely available
All compounds discussed are sold strictly for laboratory research use only. Not for human consumption.
Why a Catalog Guide Matters in 2026
Most “peptides for sale” articles focus on which supplier to buy from. This guide tackles a different question: what compounds are actually available in the Canadian research peptide market right now. The compound availability question matters because:
| Catalog Awareness Issue | Why It Matters |
|---|---|
| Many buyers don’t know what’s available | New compounds hit the Canadian market all the time. Researchers tend to default to familiar compounds when better-suited ones exist for their work |
| Category-spanning catalogs are uncommon | Most Canadian suppliers focus on certain compound categories. Finding a supplier that carries the specific compound you need can be tough without catalog awareness |
| 2026 has seen real catalog expansion | Retatrutide availability is up after the Phase 3 readouts. Cagrilintide is showing up more often. Combination blend catalogs have grown. Larger vial formats are more common now |
| Some Canadian-available compounds aren’t widely known | Specialty compounds (KPV, 5-amino-1MQ, SS-31, selank, semax, hexarelin) are available from Canadian suppliers but get less attention than mainstream compounds |
| Format diversity has grown | Past standard injectable vials, you can now find capsules, atomizer sprays, oral tablets, and combination blends for various compounds |
🎥 Watch: The 2026 Canadian Peptide Catalog Landscape
A medical practitioner walks through the current Canadian peptide research compound picture, covering what’s available, what’s new, and what to think about for different compound categories.
🧬 Category 1: Regenerative Peptides For Sale in Canada
Regenerative peptides are still the most-purchased compound category in the Canadian peptide market, pulled along by steady research interest in tissue repair, wound healing, and recovery pathways:
| Compound | What It Is | Canadian Suppliers Carrying It | Typical Strength Formats |
|---|---|---|---|
| BPC-157 | 15-amino-acid synthetic pentadecapeptide; tissue repair research | All major Canadian suppliers | 5mg, 10mg standard; 50mg (VPeptide) |
| TB-500 (Thymosin Beta-4 fragment) | 17-amino-acid actin-regulating peptide; cellular migration research | All major Canadian suppliers | 5mg, 10mg standard |
| GHK-Cu | Copper tripeptide; collagen synthesis, anti-aging research | All major Canadian suppliers; Great Northern Peptides specializes | 50mg, 100mg standard |
| KPV | Tripeptide; anti-inflammatory pathway research | Nox Peptides, Peptide Warehouse (in KLOW blends), Growth Guys, some others | 5mg, 10mg standard |
| Combination blends | Wolverine Stack (BPC-157 + TB-500), GLOW (BPC-157 + TB-500 + GHK-Cu), KLOW (BPC-157 + TB-500 + KPV + GHK-Cu), Healing Blend (BPC-157 + TB-500 at 6mg+6mg) | Peptide Warehouse (most extensive blend catalog), Growth Guys, Clinical Peptides, Nox Peptides | Multi-compound vials |
What’s new in 2026 for regenerative peptides: Combination blend availability has grown a lot. Multiple Canadian suppliers now stock pre-formulated multi-compound vials at better per-mg economics than buying parts separately. KPV specifically has picked up Canadian availability through expanded blend formulations.
🧬 Category 2: GLP-1 Class Metabolic Peptides For Sale in Canada
The GLP-1 class has seen the biggest catalog shift in 2026. Multiple pathways now exist for getting at GLP-1 class compounds:
| Compound | Mechanism | 2026 Canadian Availability | Notes |
|---|---|---|---|
| Semaglutide (Ozempic, Wegovy) | Single GLP-1 receptor agonist | Prescription pathway: original Novo Nordisk products + generic Dr. Reddy’s (approved April 28, 2026) + generic Apotex Apo-Semaglutide (approved May 1, 2026) | Research pathway: research-grade semaglutide available from all major Canadian research peptide retailers |
| Tirzepatide (Mounjaro, Zepbound) | Dual GLP-1 + GIP receptor agonist | Prescription pathway: original Eli Lilly products only (no generic, still patent protected); Research pathway: research-grade tirzepatide available from major Canadian research peptide retailers | Patent protection blocks generic competition through the late 2030s+ |
| Retatrutide | Triple GLP-1 + GIP + glucagon receptor agonist | Investigational only; research pathway: research-grade retatrutide available from major Canadian research peptide retailers; no prescription pathway available (not yet approved) | Phase 3 trials reading out through 2026; FDA submission expected late 2026/early 2027 |
| Cagrilintide | Long-acting amylin analog | Research pathway: showing up more often from Canadian research peptide retailers as CagriSema clinical development continues | Often researched in combination with semaglutide (CagriSema is the Novo Nordisk combination) |
What’s new in 2026 for the GLP-1 class: The April–May 2026 generic semaglutide approvals (Dr. Reddy’s and Apotex) split semaglutide availability into two pathways. Prescription pathway prices have started dropping while research-grade pricing stays separate. Retatrutide research availability is up after the Phase 3 readouts. Cagrilintide has picked up Canadian research availability as combination GLP-1 + amylin research grows.
🧬 Category 3: GH-Secretagogues For Sale in Canada
Growth hormone secretagogues are a mature compound category with steady Canadian availability:
| Compound | What It Is | Canadian Availability |
|---|---|---|
| CJC-1295 (with or without DAC) | GHRH analog with extended half-life (DAC version) or short half-life | All major Canadian suppliers; both DAC and no-DAC variants available |
| Ipamorelin | Selective ghrelin receptor agonist; GH-secretagogue research | All major Canadian suppliers; commonly stacked with CJC-1295 in research |
| Sermorelin | GHRH analog (29-amino-acid fragment) | Most major Canadian suppliers |
| Hexarelin | Synthetic hexapeptide GH-secretagogue | Most major Canadian suppliers |
| GHRP-2 | Growth hormone-releasing peptide-2 | Most major Canadian suppliers |
| GHRP-6 | Growth hormone-releasing peptide-6 | Most major Canadian suppliers |
| MK-677 (Ibutamoren) | Oral non-peptide ghrelin receptor agonist | Available from several Canadian suppliers including Amino Pure Canada (capsule format option) |
| Tesamorelin (Egrifta SV) | GHRH analog; HIV-lipodystrophy indication | Prescription pathway: approved as Egrifta SV by Theratechnologies for HIV-lipodystrophy; Research pathway: research-grade tesamorelin available from major Canadian research peptide retailers |
What’s new in 2026 for GH-secretagogues: Catalog stability is the main story in this category. MK-677 oral capsule format availability has grown (Amino Pure Canada in particular offers oral format options that aren’t common in the Canadian market).
🧬 Category 4: Mitochondrial-Derived Peptides For Sale in Canada
The mitochondrial peptide category is still smaller than regenerative or metabolic categories, but it’s picked up more research attention through 2025 and 2026:
| Compound | What It Is | Canadian Availability | Format Notes |
|---|---|---|---|
| MOTS-c | 16-amino-acid mitochondrial-derived peptide (mitokine) | Most major Canadian suppliers; VPeptide offers 45mg larger format | 10mg standard; 45mg larger format (VPeptide); nasal spray option (Amino Pure Canada) |
| SS-31 (Elamipretide) | Mitochondria-targeted aromatic-cationic tetrapeptide | Available from several major Canadian suppliers including Nox Peptides, Polar Peptides, Peptide Warehouse | Standard vial formats |
| Humanin | Mitochondrial-derived peptide; smaller catalog availability | Limited Canadian retail availability; specialty research compound | Standard formats when available |
What’s new in 2026 for mitochondrial peptides: VPeptide’s 45mg MOTS-c format is still the most economical larger-volume MOTS-c option in the Canadian market. Multi-format MOTS-c (nasal spray availability through Amino Pure Canada) opened up format diversity past standard injectable vials.
🧬 Category 5: Longevity Peptides For Sale in Canada
Longevity-focused research peptides are a growing but still smaller compound category:
| Compound | What It Is | Canadian Availability |
|---|---|---|
| Epitalon | Synthetic tetrapeptide; pineal gland research, telomere research | Available from most major Canadian suppliers |
| Thymosin Alpha-1 | 28-amino-acid peptide; immune function research | Available from most major Canadian suppliers |
| Thymalin | Thymus-derived peptide complex; immune research | Available from several major Canadian suppliers |
| NAD+ | Coenzyme (technically not a peptide but sold alongside peptides); cellular metabolism research | Available from several Canadian suppliers carrying broader research compound catalogs |
| DSIP (Delta sleep-inducing peptide) | 9-amino-acid peptide; sleep architecture research | Available from most major Canadian suppliers |
| 5-amino-1MQ | NNMT inhibitor; cellular methylation, adipose research | Available from several Canadian suppliers including Amino Pure Canada (oral format) |
What’s new in 2026 for longevity peptides: 5-amino-1MQ Canadian availability has grown, with multiple suppliers now stocking it, oral format options included. Epitalon is still a steady mainstay of the longevity research compound category.
🧬 Category 6: Specialty Research Peptides For Sale in Canada
| Compound | Research Application | Canadian Availability |
|---|---|---|
| PT-141 (Bremelanotide) | Melanocortin receptor research; sexual function research | Available from most major Canadian suppliers; XPeptides specializes |
| Melanotan-2 | Melanocortin receptor research; pigmentation studies | Available from most major Canadian suppliers |
| AOD9604 | Modified hGH fragment (176-191); lipolytic research | Available from most major Canadian suppliers |
| IGF-1 LR3 | Insulin-like growth factor-1 Long R3 analog; cellular growth research | Available from most major Canadian suppliers |
| IGF-1 DES | Insulin-like growth factor-1 truncated variant | Available from some Canadian suppliers |
| Follistatin (FST-344, FST-315) | Myostatin pathway research | Available from several major Canadian suppliers |
| HGH Fragment 176-191 | Human growth hormone fragment; lipolytic research | Available from most major Canadian suppliers |
| PEG-MGF | Pegylated mechano growth factor | Available from some Canadian suppliers |
| Semax | Russian-origin nootropic peptide; cognitive research | Available from some Canadian suppliers |
| Selank | Russian-origin anxiolytic peptide research | Available from some Canadian suppliers |
| ACE-031 | Activin receptor decoy; muscle research | Available from limited Canadian suppliers |
What’s new in 2026 for specialty research peptides: Russian-origin compounds (semax, selank) have held steady Canadian availability. PT-141 keeps growing as melanocortin pathway research expands. AOD9604 availability has stayed stable as lipolytic research continues.
📊 Catalog Breadth Across the Top Canadian Peptide Suppliers in 2026
| Supplier | Catalog Breadth | Particular Strengths |
|---|---|---|
| Nox Peptides | Comprehensive, spans all major research compound categories | Modern compound coverage including retatrutide, tirzepatide, MOTS-c; documentation depth across the full catalog |
| Peptide Warehouse | Comprehensive with strong combination blend focus | Most extensive blend catalog (KLOW, GLOW, Wolverine Stack); Canadian manufacturing across catalog |
| Polar Peptides | Comprehensive with detailed product specifications | Educational content across the catalog; consistent operational standards |
| Growth Guys | Broad with strong Janoshik-verification focus | Combination blends including Healing Blend; oral arginate tablet forms |
| Clinical Peptides | Comprehensive with Canadian synthesis focus | Canadian-synthesized peptides; USP-grade excipient standards; pre-made Wolverine Stack |
| Canadian Peptides | Broad mature compound coverage | Long-tenure catalog with reliable availability across mature compounds |
| VPeptide | Focused with larger vial format specialty | 45mg MOTS-c, 50mg BPC-157, larger format specialty |
| Luxara Labs | Premium focused on high-value compounds | Premium positioning particularly strong for retatrutide, tirzepatide, semaglutide research-grade |
| NCRP | Focused with manufacturer-direct pricing | Manufacturer-direct catalog across mature compounds |
| Amino Pure Canada | Multi-format catalog (capsule, vial, atomizer) | Format diversity including capsule MK-677, nasal spray MOTS-c |
| Great Northern Peptides | Focused with GHK-Cu specialty | GHK-Cu Freedom Diagnostics-verified specialty positioning |
| Purity Peptides | Broad with non-China sourcing emphasis | Documented North American supply chain across catalog |
📊 The Compound-Specific Buying Decision Map
| If you’re looking to buy… | The Canadian suppliers most strongly positioned are… |
|---|---|
| BPC-157 (any format) | Nox Peptides (documentation), VPeptide (50mg larger format), Peptide Warehouse (Made-in-Canada), Growth Guys (Janoshik) |
| TB-500 / Thymosin Beta-4 | Nox Peptides, Polar Peptides, Peptide Warehouse, Growth Guys |
| GHK-Cu (copper tripeptide) | Nox Peptides, Great Northern Peptides (Freedom Diagnostics specialty), Peptide Warehouse |
| KPV | Nox Peptides, Peptide Warehouse (in KLOW blends), Growth Guys |
| Wolverine Stack / GLOW / KLOW blends | Peptide Warehouse (most extensive blend catalog), Clinical Peptides (pre-made Wolverine Stack), Growth Guys (Healing Blend) |
| Retatrutide (research-grade) | Nox Peptides (documentation for high-value compound), Luxara Labs (premium positioning), Growth Guys |
| Tirzepatide (research-grade) | Nox Peptides, Luxara Labs, Growth Guys, Polar Peptides |
| Semaglutide (research-grade) | Nox Peptides, Polar Peptides, Growth Guys, Clinical Peptides |
| Semaglutide (prescription, different pathway) | Licensed Canadian pharmacy with prescription from a licensed Canadian prescriber (Novo Nordisk products + generic Dr. Reddy’s + generic Apotex Apo-Semaglutide) |
| Cagrilintide | Nox Peptides, Growth Guys, several major Canadian suppliers |
| MOTS-c (any format) | VPeptide (45mg larger format), Nox Peptides, Amino Pure Canada (nasal spray) |
| SS-31 (Elamipretide) | Nox Peptides, Polar Peptides, Peptide Warehouse |
| CJC-1295 / Ipamorelin / Sermorelin / GHRP-2 / GHRP-6 / Hexarelin | All major Canadian suppliers; price and format competition is heavy in this category |
| MK-677 (oral capsule format) | Amino Pure Canada (specifically capsule format), several others (vial format) |
| Tesamorelin (research-grade) | Nox Peptides, Polar Peptides, others; for prescription Egrifta SV, licensed Canadian pharmacy |
| Epitalon / Thymosin Alpha-1 / Thymalin | Most major Canadian suppliers |
| PT-141 (Bremelanotide) | Nox Peptides, XPeptides (specialty), Polar Peptides |
| Melanotan-2 | Most major Canadian suppliers |
| AOD9604 / HGH Fragment 176-191 | Most major Canadian suppliers |
| IGF-1 LR3 / IGF-1 DES | Most major Canadian suppliers |
| Follistatin (FST-344, FST-315) | Several major Canadian suppliers |
| 5-amino-1MQ | Amino Pure Canada (oral format), several others |
| DSIP (Delta sleep-inducing peptide) | Most major Canadian suppliers |
| NAD+ (sold alongside peptides) | Several Canadian suppliers with broader research compound catalogs |
| Semax / Selank (Russian-origin nootropic / anxiolytic) | Several Canadian suppliers carrying specialty research compounds |
| PEG-MGF / ACE-031 | Limited Canadian supplier availability; contact suppliers directly for specialty compound availability |
📊 What’s NOT Generally For Sale in Canadian Research Peptide Markets
| Compound Type | Why It’s Not Generally Available |
|---|---|
| Schedule I/II controlled substances | Falls under the Controlled Drugs and Substances Act. Not legally available for research peptide retail |
| Patented prescription drugs (in research-grade) | Some compounds (specific patented brand drugs) aren’t usually sold in research-grade form by Canadian peptide retailers |
| Customized peptide synthesis | Canadian peptide retailers stock standard compounds. Custom peptide synthesis needs specialized peptide synthesis companies, not retail suppliers |
| Veterinary-specific peptide formulations | Most Canadian peptide retailers focus on research applications. Veterinary-specific formulations usually need specialized veterinary research suppliers |
| Clinical-grade certified peptides | Canadian research peptide retailers don’t usually provide clinical-grade certification. Clinical trial supplies need pharmaceutical manufacturers |
| Compounds available only by prescription | Health Canada-approved peptide drugs (Ozempic, Wegovy, Mounjaro, Egrifta SV) need the prescription pathway through licensed Canadian pharmacies, not research peptide retailers |
📊 Catalog Evolution: 2024 → 2025 → 2026
| Catalog Change | 2024 → 2025 | 2025 → 2026 |
|---|---|---|
| Retatrutide availability | Limited Canadian retail availability | Broader Canadian availability after Phase 3 readouts; multiple major suppliers |
| Tirzepatide availability | Growing Canadian retail availability | Established availability across major Canadian suppliers |
| Generic semaglutide | Not available (Health Canada generic approvals pending) | Approved: Dr. Reddy’s (April 28, 2026) and Apotex (May 1, 2026); 8+ more generic submissions under review |
| Cagrilintide | Specialty research only | Wider Canadian retail availability as CagriSema clinical development moves forward |
| Combination blends | Growing supplier offering | Established catalog across multiple suppliers (KLOW, GLOW, Wolverine Stack, Healing Blend) |
| Larger vial formats | 10mg–20mg standard maximums | 45mg+ MOTS-c, 50mg+ BPC-157, 30mg+ retatrutide widely available |
| Multi-format options | Mostly injectable vials | Capsule MK-677, nasal spray MOTS-c, oral tablet BPC-157 (arginate form), atomizer sprays available |
| Documentation depth | HPLC purity standard | Endotoxin testing per batch entering the market (Nox Peptides as the documented leader) |
📚 Authority Sources for Canadian Peptide Catalog Awareness
- 🇨🇦 Health Canada — Think twice before injecting peptides bought online (April 2026)
- 🇨🇦 Health Canada — Drug Product Database
- 📰 CBC News — Health Canada warns against unauthorized peptides (April 2026)
- 📰 Apotex — Apo-Semaglutide Health Canada approval announcement (May 2026)
- 💼 Eli Lilly — Investor Relations & Clinical Trial Updates
- 📘 New England Journal of Medicine — Clinical Research Publications
- ⚕️ College of Physicians & Surgeons of Alberta — Unauthorized injectable peptides
- 🎓 McMaster University — Research-Only Peptides Q&A
- 🎓 McGill University Office for Science and Society
- 🏃 World Anti-Doping Agency — Prohibited List
Frequently Asked Questions
How many distinct peptides are for sale in Canada in 2026?
Roughly 40+ distinct research compounds are currently for sale across the Canadian research peptide market, spanning regenerative peptides, GLP-1 class metabolic peptides, GH-secretagogues, mitochondrial-derived peptides, longevity peptides, and specialty research compounds. The exact count moves around as new compounds come into the market and older or specialty compounds become less commonly stocked. Combination blends (multi-compound vials) add more product variety on top of individual compounds.
Which Canadian peptide supplier has the broadest catalog?
Several Canadian suppliers carry wide catalogs spanning most major compound categories: Nox Peptides (modern catalog with documentation depth across all categories), Peptide Warehouse (comprehensive with strong combination blend focus), Polar Peptides (comprehensive with detailed product specs), Clinical Peptides (Canadian synthesis across the catalog), Canadian Peptides (mature compound coverage), and Growth Guys (broad with Janoshik verification across the catalog). Catalog breadth on its own isn’t the only thing to look at. Specialty positioning often matters more for specific compounds (Great Northern Peptides for GHK-Cu, VPeptide for larger MOTS-c formats, Amino Pure Canada for multi-format options, and so on).
What’s the newest compound for sale in the Canadian peptide market?
Several compounds have picked up wider Canadian retail availability through 2025 and 2026: retatrutide (broader availability after Phase 3 readouts), cagrilintide (more available as CagriSema clinical development moves forward), MOTS-c larger formats (45mg vials becoming common), and combination blends (KLOW, GLOW, Healing Blend expanding across suppliers). The April–May 2026 generic semaglutide approvals (Dr. Reddy’s, Apotex) opened up new prescription pathway availability separate from the research-grade pathway that’s been around.
Can I buy custom peptide synthesis in Canada?
Generally no, not from retail Canadian peptide suppliers. Canadian research peptide retailers stock standard compounds at standard formats. Custom peptide synthesis needs specialized peptide synthesis companies running different business models, usually contracted academic or pharmaceutical research applications with longer lead times and higher minimum orders. The retail Canadian peptide market focuses on commonly-researched compounds available off the shelf.
What peptides are available in capsule or oral formats in Canada?
Capsule and oral format peptide availability in Canada is limited compared to standard injectable vial formats. Amino Pure Canada has the most extensive multi-format catalog including capsule MK-677, oral MOTS-c, and other format alternatives. Growth Guys carries oral arginate tablet forms (specifically BPC-157 in tablet form). Most other Canadian suppliers stick to standard injectable lyophilized vials. For researchers who need oral format compounds specifically, multi-format suppliers are the right sourcing path.
What’s the difference between research-grade and pharmaceutical-grade peptides available in Canada?
Research-grade peptides (carried by Canadian research peptide retailers): sold strictly for laboratory research and in vitro experimental use; not approved by Health Canada as drugs; no Drug Identification Number (DIN); typically lower per-mg cost; available without prescription. Pharmaceutical-grade peptides (carried by licensed Canadian pharmacies with prescription): Health Canada-approved as drugs; carry an 8-digit DIN; typically much higher per-mg cost; need a valid prescription from a licensed Canadian prescriber; approved for human therapeutic use within indicated conditions. The two categories run under totally different regulatory frameworks and aren’t interchangeable.
Are combination peptide blends popular in the 2026 Canadian market?
Yes, and more so each year. Combination blends like Wolverine Stack (BPC-157 + TB-500), GLOW (adds GHK-Cu), KLOW (adds KPV), and Healing Blend (BPC-157 + TB-500 at 6mg + 6mg dosing) have grown in catalog availability through 2024 to 2026. Multiple Canadian suppliers now stock pre-formulated combination blend products. The economic case is real. Blend procurement usually delivers 20–40% per-mg savings versus buying the components separately, and it cuts down the procurement work for multi-pathway research protocols.
Which Canadian suppliers carry the most modern compounds (retatrutide, cagrilintide, MOTS-c)?
Suppliers with explicit modern catalog focus: Nox Peptides (carries the full modern catalog with documentation depth; retatrutide, tirzepatide, semaglutide, MOTS-c, cagrilintide), Luxara Labs (premium positioning particularly for retatrutide and tirzepatide), Growth Guys (Janoshik-verified modern catalog), Polar Peptides (educational content + modern catalog). Some Canadian suppliers stick mostly to mature compounds and may have limited or no modern compound availability. Researchers who want modern catalog access should prioritize suppliers that explicitly position around contemporary research compounds.
What peptides should I avoid trying to buy in the Canadian retail market?
Compounds that usually aren’t available in legitimate Canadian retail peptide markets: Schedule I/II controlled substances, patented brand-name pharmaceutical products in research-grade form (some specific patented drugs aren’t usually sold by research peptide retailers), customized synthesis of unusual sequences, and Health Canada-approved prescription drugs through non-prescription pathways. If you find a Canadian “supplier” claiming to offer compounds that usually aren’t available in legitimate Canadian markets, treat the offering with heavy skepticism. It’s likely either misrepresentation or operating outside legitimate regulatory frameworks.
How is the Canadian peptide catalog evolving for 2026 and 2027?
Toward wider modern compound availability and continued format diversification. Retatrutide retail availability is likely to keep growing as the Phase 3 program wraps. Cagrilintide availability is likely to grow as combination GLP-1 + amylin research expands. Multi-format options (oral, nasal spray, sublingual) are likely to spread across more compounds as research moves past injectable-only protocols. Documentation depth is becoming a stronger competitive dimension, with verification-leading suppliers picking up catalog momentum. The path through 2027 points to broader compound availability, more format diversity, and deeper verification across the Canadian peptide catalog.
⚖️ Legal Disclaimers
Research Use Only. All peptide products referenced in this article are sold and intended strictly for laboratory research and in vitro experimental use. They are not intended for human consumption, injection, ingestion, inhalation, topical application, or any other form of human use, nor for veterinary use, food, or cosmetic applications.
Not Approved by Health Canada. The compounds discussed (excluding approved prescription medications obtained through licensed Canadian pharmacies with valid prescriptions) aren’t approved as drugs by Health Canada or by the U.S. Food and Drug Administration. They haven’t been through the clinical safety and efficacy review that authorized prescription medications go through. Authorized drugs for sale in Canada carry an 8-digit Drug Identification Number (DIN) on the label.
Health Canada April 2026 Advisory. Health Canada issued a public warning on April 10, 2026 against using unauthorized injectable peptide drugs bought online, citing risks including hormonal imbalance, mood swings, blood sugar imbalance, liver or kidney damage, blood clots, growth of cancerous tumours, infections, allergic reactions, and interactions with other medications.
Catalog Information Methodology. The catalog availability assessments in this article reflect publicly available information about Canadian peptide market conditions, supplier business operations, and compound availability patterns observable as of publication. Catalog availability varies by specific supplier, batch availability, market conditions, and other factors. Specific compounds may not be available at all listed suppliers at all times. Always check current compound availability directly with any supplier before assuming catalog presence.
Different Pathways Disclaimer. The Canadian peptide market has multiple distinct regulatory pathways: prescription pharmaceutical pathway (Ozempic, Wegovy, Mounjaro, Egrifta SV, generic semaglutide), research-grade pathway (compounds discussed in this article), cosmetic pathway (topical peptide products), and veterinary research pathway. These pathways run under entirely different regulatory frameworks and aren’t interchangeable. This article addresses the research-grade pathway specifically.
No Endorsement of Personal Use. Including any compound or supplier in this guide reflects public business activity in the Canadian research-use peptide market and does not constitute an endorsement, recommendation, or invitation to use any compound outside a controlled laboratory research setting.
No Medical Advice. This article is published for educational and informational purposes only. It doesn’t constitute medical advice, prescription guidance, diagnosis, or treatment recommendation. Anyone thinking about peptide-based therapies for personal health purposes should talk to a licensed Canadian healthcare professional and get authorized prescription medications through a licensed Canadian pharmacy.
Buyer Compliance. Buyers are solely responsible for compliance with all applicable federal, provincial, and municipal laws, regulations, and institutional policies in their jurisdiction, including Canada’s Food and Drugs Act, Controlled Drugs and Substances Act, Health Canada regulatory frameworks, and any institutional research ethics board (REB) requirements.
Anti-Doping Compliance. Many research peptides are listed on the World Anti-Doping Agency Prohibited List. Athletes subject to WADA Code or any sport-governing-body anti-doping regulations should talk to their compliance officer before sourcing or possessing any peptide compound.
Limited Human Evidence. The human clinical trial evidence base for most popular research peptides is extremely thin. Anecdotal reports and preclinical animal data don’t constitute clinical proof of safety or efficacy in humans.
Information Currency. Compound catalog availability, supplier operations, regulatory frameworks, and Canadian peptide market conditions change fast. Information in this article is current as of publication date and subject to change. Always check current compound availability, catalog details, and quality documentation directly with any supplier before purchase.
No Liability. This publication, its authors, and Nox Peptides take no liability for decisions readers make based on the information provided here. Compound selection, supplier selection, and any consequences are the buyer’s sole responsibility.
The 2026 Bottom Line
Peptides for sale in Canada in 2026 cover a meaningfully broader catalog than 2024, roughly 40+ distinct research compounds spanning regenerative peptides, GLP-1 class metabolic peptides, GH-secretagogues, mitochondrial-derived peptides, longevity peptides, and specialty research compounds. Throw in combination blends, larger vial formats, and multi-format options (capsule, nasal spray, oral tablet alternatives to standard injectable vials), and the Canadian peptide market offers more compound variety than ever.
What’s new for sale in 2026: retatrutide availability is up after the Phase 3 readouts; cagrilintide is more available; generic semaglutide hit the prescription pathway (Dr. Reddy’s April 28, 2026; Apotex May 1, 2026); combination blend catalogs have grown across multiple suppliers; larger vial formats (45mg MOTS-c, 50mg BPC-157, 30mg+ retatrutide) are widely available; documentation depth has come in as a competitive dimension with endotoxin testing per batch now available from Nox Peptides.
Nox Peptides stands out as the Canadian supplier carrying the broadest documented catalog. Modern compound coverage (retatrutide, tirzepatide, MOTS-c, cagrilintide) alongside mature compounds, with documentation depth that no other Canadian retail peptide market player matches through combined per-batch purity and endotoxin testing. For buyers who want both catalog breadth AND verification depth in 2026, Nox Peptides is the strongest default starting point.
The other major Canadian suppliers fill specialized catalog positions: Peptide Warehouse for combination blends and Canadian manufacturing, Polar Peptides for educational content + detailed specifications, Growth Guys for Janoshik-verified catalog, Clinical Peptides for Canadian synthesis + loyalty mechanics, Canadian Peptides for mature compound reliability, VPeptide for larger vial format specialty, Luxara Labs for premium positioning particularly on high-value compounds, NCRP for manufacturer-direct pricing, Amino Pure Canada for multi-format options (capsules, atomizers), Great Northern Peptides for GHK-Cu Freedom Diagnostics specialty, Purity Peptides for documented North American supply chain, and PeptidePro Canada for fast central-Canada delivery.
What no Canadian buyer should assume about peptides for sale in Canada: that all compounds are available from all suppliers, that compound availability stays stable across time, that “for sale” claims always match actual stock, or that catalog breadth makes up for verification depth. Always check current compound availability and quality documentation directly with any supplier before purchase.
For Canadian buyers ready to browse the broadest documented catalog in the Canadian research peptide market, check the catalog and per-batch lab reports at noxpeptides.ca.
Last updated: 2026. Compound catalog availability, supplier operations, regulatory information, and Canadian peptide market conditions current as of publication date and subject to change. Always check current compound availability and quality documentation directly with any supplier before purchase. Consult Health Canada and the College of Physicians & Surgeons in your province for current guidance. All information provided for educational purposes only. Not medical advice.
